Skip to main content
. 2014 Jan 25;10:30. doi: 10.1186/1746-6148-10-30

Figure 1.

Figure 1

In vitro antiproliferative effects of VDC-1101 against human multiple myeloma-derived cell lines. Three human myeloma-derived cell lines were incubated with varying concentrations of drug for 5 days, followed by determination of relative viable cell number using a luminescent cell viability assay. VDC-1101 demonstrated dose-dependent inhibition of cell growth in all cell lines examined. Error bars indicate SEM.